RESENCATINIB

UNII:	VW69FG2AYB
Type:	INGREDIENT SUBSTANCE
Formula:	C₃₀H₂₉N₇O₃
Preferred Substance Name:	RESENCATINIB
InChIKey:	WNPSOODWDSNATA-DPHZAUTASA-N
GSRS Full Record:	VW69FG2AYB i

2546117-79-5
6-[(2R)-2-hydroxy-2-methylbut-3-ynoxy]-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-3-pyridinyl]pyrazolo[1,5-a]pyridine-3-carbonitrile
6-[[(2R)-2-Hydroxy-2-methyl-3-butyn-1-yl]oxy]-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]hept-3-yl]-3-pyridinyl]pyrazolo[1,5-a]pyridine-3-carbonitrile
6-{[(2R)-2-hydroxy-2-methylbut-3-yn-1-yl]oxy}-4-(6-{6- [(6-methoxypyridin-3-yl)methyl]-3,6- diazabicyclo[3.1.1]heptan-3-yl}pyridin-3- yl)pyrazolo[1,5-a]pyridine-3-carbonitrile
Pyrazolo[1,5-a]pyridine-3-carbonitrile, 6-[[(2R)-2-hydroxy-2-methyl-3-butyn-1-yl]oxy]-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]hept-3-yl]-3-pyridinyl]-
Resencatinib
resencatinib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

RESENCATINIB

Synonyms and Mappings

Resources